These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22791442)

  • 21. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
    Dhumal RS; Biradar SV; Paradkar AR; York P
    Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expanding role of aerosols in systemic drug delivery, gene therapy, and vaccination.
    Laube BL
    Respir Care; 2005 Sep; 50(9):1161-76. PubMed ID: 16122400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler.
    Williams RO; Repka M; Liu J
    Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
    Merisko-Liversidge E; Liversidge GG
    Adv Drug Deliv Rev; 2011 May; 63(6):427-40. PubMed ID: 21223990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel nanoparticles for pulmonary drug administration.
    Dickinson PA; Howells SW; Kellaway IW
    J Drug Target; 2001; 9(4):295-302. PubMed ID: 11697032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of inhalable formulations of anti-inflammatory drugs to potentially treat smoke inhalation injury in burn victims.
    Thai A; Xiao J; Ammit AJ; Rohanizadeh R
    Int J Pharm; 2010 Apr; 389(1-2):41-52. PubMed ID: 20080165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate.
    Alhusban FA; Seville PC
    J Microencapsul; 2009 Aug; 26(5):444-55. PubMed ID: 18855201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery.
    Beck-Broichsitter M; Schweiger C; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Mar; 158(2):329-35. PubMed ID: 22063006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
    Azarmi S; Tao X; Chen H; Wang Z; Finlay WH; Löbenberg R; Roa WH
    Int J Pharm; 2006 Aug; 319(1-2):155-61. PubMed ID: 16713150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal ink-jet spray freeze-drying for preparation of excipient-free salbutamol sulphate for inhalation.
    Mueannoom W; Srisongphan A; Taylor KM; Hauschild S; Gaisford S
    Eur J Pharm Biopharm; 2012 Jan; 80(1):149-55. PubMed ID: 22001519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanotechnology and pharmaceutical inhalation aerosols.
    Patel AR; Vavia PR
    Indian J Exp Biol; 2007 Feb; 45(2):166-74. PubMed ID: 17375556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary delivery of therapeutic peptides via dry powder inhalation: effects of micronisation and manufacturing.
    Irngartinger M; Camuglia V; Damm M; Goede J; Frijlink HW
    Eur J Pharm Biopharm; 2004 Jul; 58(1):7-14. PubMed ID: 15207532
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-micro- and nanoparticles for pulmonary delivery.
    Klingler C; Müller BW; Steckel H
    Int J Pharm; 2009 Jul; 377(1-2):173-9. PubMed ID: 19446621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and characterization of spray dried inhalable powders containing chitosan nanoparticles for pulmonary delivery of isoniazid.
    Pourshahab PS; Gilani K; Moazeni E; Eslahi H; Fazeli MR; Jamalifar H
    J Microencapsul; 2011; 28(7):605-13. PubMed ID: 21793647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a biodegradable nanoparticle platform for sildenafil: formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters.
    Beck-Broichsitter M; Schmehl T; Gessler T; Seeger W; Kissel T
    J Control Release; 2012 Feb; 157(3):469-77. PubMed ID: 21930166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particle engineering techniques for inhaled biopharmaceuticals.
    Shoyele SA; Cawthorne S
    Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1009-29. PubMed ID: 17005293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
    Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained delivery by leucine-modified chitosan spray-dried respirable powders.
    Learoyd TP; Burrows JL; French E; Seville PC
    Int J Pharm; 2009 May; 372(1-2):97-104. PubMed ID: 19429272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.